QuantumScape Corp — Director's Dealing 2022

Mar 25, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: QuantumScape Corp (QS)
CIK: 0001811414
Period of Report: 2022-03-23

Reporting Person: Leohold Jurgen (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-03-23	Class A Common Stock	M	4283	$1.3252	Acquired	156872	Direct
2022-03-23	Class A Common Stock	M	10000	$2.377	Acquired	166872	Direct
2022-03-23	Class A Common Stock	S	14283	$18.002	Disposed	152589	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-03-23	Stock Option (right to buy)	$1.3253	M	4283	Disposed	2027-12-13	Class A Common (4283)	Direct
2022-03-23	Stock Option (right to buy)	$2.377	M	10000	Disposed	2029-12-11	Class A Common (10000)	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in September 2021.

F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.015, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

F3: Includes 5,294 shares represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Class A Common Stock of the Issuer. 100% of the RSUs vest on the first quarterly vesting date following the one-year anniversary of the grant date, subject to the Reporting Person's continued service as of the vesting date.

F4: 20% of the shares subject to the option vested and became exercisable on January 1, 2019, and the remaining shares will vest monthly thereafter, subject to the Reporting Person's continued service at each vesting date.

F5: 20% of the shares subject to the option will vest and become exercisable on December 11, 2020, and the remaining shares will vest monthly thereafter, subject to the Reporting Person's continued service at each vesting date.